Anti-Inflammatory's Flashcards
Why should glucocorticoids be avoided in the elderly?
Their bones are already thinned
Their skin is already thin
They already bruise easily
***
What is a Sweatman-mentioned way to increase the likelihood of proving that your drug works (in clinical trials)?
Carefully select your patient population for the trial based upon their genetic makeup
This eliminates those who will not respond to anything, for example
MOA of anti-histamines:
Inverse agonists (shifts the receptor into an inactive state)
How can the negative effects of chronic steroid use be avoided in asthmatics?
Inhalers
applied directly in small doses
What does a phosphodiesterase inhibitor do, in general terms?
Suppresses immune and inflammatory activity
What is the drug of choice for immuno suppression in connection with renal transplantation?
Thyroglobulin
What are the long term effects if immunosuppressant drugs?
Not yet determined…
Grafts in order of immunogenicity (most to least): Heart Kidney Liver Lung
Lung > heart > kidney > liver
What drives variation in the selection of maintenance drugs following transplant?
Risk (of rejection?)
Type of transplant (due to graft immunogenicity)
Medication related toxicities
Effects of corticosteroids on neutrophils:
Neutrophilia:
Increase production
Decrease apoptosis
Effect of corticosteroid on eosinophils:
Increase apoptosis (eosinopenia)
Effects of corticosteroids on monocytes:
Monocytopenia:
Decrease production
Decrease differentiation
What is the difference between 1st and 2nd generation anti-histamines?
1st is able to cross the blood brain barrier
What is the benefit of 1st generation anti-histamines?
Can treat Parkinson’s, insomnia, vertigo, etc
What is the benefit of 2nd generation anti-histamines?
They don’t cause drowsiness
What are inflammatory reactions often difficult to control?
There are usually many overlapping cytokine reactions mediating them
(Symptoms may be due to different cytokines or different reaction to a cytokines)
3 Ways to alter cytokines effects: (general)
- Block the action at the source
- Block action once it has been released
- Black action at/within the target cell
2 Ways to block cytokines at the source:
- Block transcriptional regulation
* Inhibit synthesis
3 Ways to block cytokine action after its released:
- Blocking monoclonal antibody (soak up the cytokine before it reaches its target tissue)
- Fake soluble receptor (attracts cytokine and binds so it never reaches the correct tissue)
- Cytokine antagonist (binds to surface receptor on target cell)
2 Ways to block cytokine action in target cell:
- Inhibit the transcription factor
* Interrupt transcriptional regulation to diminish the consequences of the cytokine
What are the treatment goals in early vs late phase of asthma attack?
- Early phase: controlling the bronchospasm
* Late phase: controlling the inflammation
2 important rules for glucocorticoid use in asthma therapy:
- only use systemically for a short duration (due to adverse effects)
- Use inhaled glucocorticoids (instead) to control long term
- local/direct application
- no systemic dose of meds = no adverse
2 important rules for glucocorticoid use in asthma therapy:
- only use systemically for a short duration (due to adverse effects)
- Use inhaled glucocorticoids (instead) to control long term
- local/direct application
- no systemic dose of meds = no adverse
This drug binds to importin-alpha to gain access to the cell.
glucocorticoid
This drug decreases production of inflammatory cytokines.
glucocorticoid
6 Possible reasons that a patient is not responding to glucocorticoids.
- Defective histone acetylation
- Efflux via active pumps
- Differences in ratio/distribution of α and β receptor types
- Familial resistance
- Receptor is modification
- Other inflammatory mediators are involved that are not acted on by glucocorticoids